Repurposing therapeutics for COVID-19: Rapid prediction of commercially available drugs through machine learning and docking.

ABSTRACT:

Background

The outbreak of the novel coronavirus disease COVID-19, caused by the SARS-CoV-2 virus has spread rapidly around the globe during the past 3 months. As the virus infected cases and mortality rate of this disease is increasing exponentially, scientists and researchers all over the world are relentlessly working to understand this new virus along with possible treatment regimens by discovering active therapeutic agents and vaccines. So, there is an urgent requirement of new and effective medications that can treat the disease caused by SARS-CoV-2.

Methods and findings

We perform the study of drugs that are already available in the market and being used for other diseases to accelerate clinical recovery, in other words repurposing of existing drugs. The vast complexi

SUBMITTER: Mohapatra S 

PROVIDER: S-EPMC7660547 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature